Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,20508,836,0.97 [0.85-1.12],0.7206089782575502
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,20467,164,1.07 [0.80-1.44],0.6405373120002429
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22132,161,1.18 [0.91-1.53],0.2228480014515225
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,15599,629,1.13 [0.98-1.31],0.0898159356178158
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22076,105,1.00 [0.68-1.47],0.9927240844122888
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21213,76,1.16 [0.80-1.70],0.430381576974938
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23255,104,0.99 [0.68-1.45],0.9677781077303916
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23249,69,1.13 [0.74-1.70],0.5735125743852201
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20672,49,1.03 [0.60-1.79],0.9080834762659976
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,22719,104,1.15 [0.82-1.60],0.4197928563524896
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22680,65,0.98 [0.60-1.60],0.940483446591066
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23318,67,0.63 [0.34-1.18],0.1517548899294185
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23294,85,1.03 [0.69-1.54],0.8968020780136425
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23291,82,1.08 [0.73-1.60],0.6906948285105218
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Mycoses,22999,58,1.49 [1.08-2.06],0.0155675888067398
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22326,359,0.74 [0.57-0.95],0.0196192172475856
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22080,113,0.63 [0.39-1.03],0.0675214907473746
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22215,248,0.74 [0.55-1.01],0.0555616222354447
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",19083,44,1.32 [0.86-2.05],0.2062239319854787
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19093,54,0.86 [0.48-1.54],0.6077639000556702
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19260,221,1.07 [0.83-1.36],0.6148930220411793
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19267,228,1.08 [0.85-1.37],0.5504592083600655
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",19609,570,0.96 [0.81-1.13],0.5996655098776228
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19086,47,1.07 [0.63-1.82],0.8036608369043058
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,20936,868,1.14 [1.01-1.28],0.0405454078033683
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22429,253,1.03 [0.81-1.31],0.7951189745948556
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23030,100,0.96 [0.65-1.44],0.8610433748408003
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23401,80,1.01 [0.66-1.54],0.971327415703419
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Rectum,23220,54,0.99 [0.59-1.67],0.9637440730897616
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23399,58,1.21 [0.79-1.85],0.3802711714781147
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Stomach,23444,44,1.32 [0.85-2.05],0.2135834748184164
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm,23257,243,1.11 [0.88-1.39],0.3761519848540716
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23399,99,0.99 [0.67-1.46],0.9493932907280846
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23400,92,1.35 [1.01-1.80],0.0423482587988409
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23334,61,0.89 [0.51-1.52],0.6623421024283493
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Haemangioma, any site",23336,60,0.89 [0.52-1.54],0.6778207298763799
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Melanocytic naevi,23253,227,0.89 [0.67-1.17],0.4007695518956986
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,23402,107,0.55 [0.33-0.93],0.0245072198800421
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Other benign neoplasms of skin,23308,193,1.02 [0.78-1.34],0.8663430070639273
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm of breast,23388,120,1.19 [0.89-1.59],0.2493815217802859
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Leiomyoma of uterus,22970,852,1.03 [0.90-1.17],0.6823757838724922
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22289,230,1.27 [1.04-1.55],0.0192281242649834
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22052,377,1.24 [1.05-1.45],0.0105135967987447
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22052,377,1.24 [1.05-1.45],0.0105135967987447
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),20756,333,0.95 [0.76-1.19],0.6629763818526073
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22938,84,1.02 [0.68-1.53],0.9313815182260624
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23151,82,1.13 [0.78-1.64],0.5099805370505834
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,19446,750,0.95 [0.81-1.11],0.5011270788051372
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,21500,747,1.14 [1.01-1.30],0.0373792774600687
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,21875,92,1.28 [0.93-1.75],0.1276304180614257
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22564,46,1.45 [0.99-2.14],0.0565229038259929
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,21865,82,1.32 [0.96-1.82],0.0913375319381315
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,22127,344,1.14 [0.93-1.39],0.2035729126596266
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22117,334,1.11 [0.91-1.37],0.2975524388291921
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,21694,158,1.06 [0.76-1.46],0.7323197355547366
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",21696,155,1.05 [0.76-1.46],0.7572947652140204
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19280,584,0.92 [0.77-1.10],0.3659420052370288
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",18764,68,0.98 [0.60-1.59],0.9321321617676044
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,19240,544,0.92 [0.76-1.11],0.3941264290407174
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,18741,45,0.96 [0.52-1.77],0.90577011521257
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",18752,56,0.90 [0.51-1.59],0.7100098625241635
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Any mental disorder,19793,506,1.04 [0.88-1.23],0.6308286900005089
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19384,97,0.92 [0.60-1.42],0.7129159946761898
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23233,63,0.90 [0.52-1.54],0.6997831382503665
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23265,37,0.68 [0.29-1.57],0.3637736845109509
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,22218,32,1.31 [0.77-2.23],0.3167890271338073
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23402,32,1.31 [0.77-2.22],0.3197041090572117
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",19319,32,1.30 [0.77-2.20],0.3257084046216841
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Alcohol dependence,22208,22,0.93 [0.37-2.32],0.8769325896188815
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Smoking dependency,22125,30,1.16 [0.62-2.20],0.6424668124628337
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19325,38,1.13 [0.64-1.98],0.6787047773859041
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19595,308,0.99 [0.80-1.24],0.9508079476945124
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Depression,21747,275,0.99 [0.79-1.25],0.9420756970122904
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Depression or dysthymia,19417,238,1.03 [0.81-1.31],0.7917503984066215
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19413,126,1.13 [0.84-1.52],0.430667111772531
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Other anxiety disorders,21820,64,0.77 [0.43-1.37],0.3706174616952472
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Neurological diseases,20314,1386,1.02 [0.92-1.14],0.6622292950635654
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18584,161,0.96 [0.71-1.30],0.797895562035419
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23274,131,0.84 [0.58-1.23],0.3752916958376692
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22338,362,1.08 [0.90-1.31],0.4011323288676178
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Epilepsy,22090,114,1.22 [0.91-1.63],0.1936146866992706
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Migraine,22082,106,0.69 [0.43-1.11],0.1298144668922091
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23064,98,0.71 [0.43-1.15],0.1624843806524908
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22861,51,1.23 [0.79-1.91],0.3620787060325707
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other sleep disorders,22063,87,1.22 [0.86-1.73],0.2557782675803516
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Sleep apnoea,23095,61,1.22 [0.81-1.82],0.3408515605953112
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22273,714,0.94 [0.80-1.09],0.3959256076110617
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21661,102,0.90 [0.60-1.36],0.6198111417125072
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22012,453,0.92 [0.75-1.12],0.3932666960701492
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23228,64,1.15 [0.76-1.75],0.4970994619697346
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Hemiplegia,23213,49,1.15 [0.72-1.85],0.5492722881487601
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other neurological diseases,23028,104,1.18 [0.86-1.62],0.3114400274136059
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22815,364,1.17 [0.98-1.40],0.0842619399697739
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22660,209,1.11 [0.87-1.42],0.409447377283215
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22513,62,1.35 [0.94-1.93],0.108084691805469
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22563,112,1.08 [0.77-1.53],0.6503781601205953
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22542,91,1.05 [0.71-1.56],0.802674970420394
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,19901,145,1.02 [0.74-1.41],0.9049584381873376
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20111,355,0.97 [0.79-1.21],0.8133397502772997
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22561,150,0.90 [0.63-1.27],0.5413079995907648
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23218,28,0.91 [0.41-2.02],0.8128501100700212
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1500,28,0.94 [0.38-2.34],0.901892639778442
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",21746,28,0.92 [0.42-2.02],0.8262897191700913
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,22848,76,1.12 [0.75-1.68],0.5809549217349511
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22811,39,1.02 [0.55-1.88],0.956511836787258
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",22718,77,0.87 [0.54-1.42],0.5870620981643226
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22939,89,1.37 [1.02-1.83],0.0379962716899547
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23335,106,1.21 [0.89-1.65],0.2188204209133246
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,22777,93,1.04 [0.71-1.53],0.8464050690373327
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,17244,2351,1.00 [0.92-1.10],0.92847618505107
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,22962,66,1.47 [1.07-2.01],0.0165022088559377
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Hypertension, essential",18142,1728,1.02 [0.92-1.14],0.666136363818796
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypertension,18157,1743,1.02 [0.92-1.13],0.7276492934133991
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16446,32,0.58 [0.22-1.52],0.2674822754559126
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22031,602,1.00 [0.84-1.18],0.9602665791132268
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Angina pectoris,21848,419,1.13 [0.95-1.35],0.1664151400881877
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22876,122,0.98 [0.69-1.41],0.9260959292643224
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22940,186,0.86 [0.62-1.19],0.3587144946646107
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23381,24,0.14 [0.04-0.55],0.0045301226224385
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",21506,77,0.68 [0.38-1.22],0.199102068684229
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21808,388,1.01 [0.82-1.23],0.95081508848231
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22764,85,1.15 [0.80-1.67],0.4537827487594784
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22858,184,1.12 [0.86-1.45],0.3946071491576722
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22767,88,1.32 [0.97-1.80],0.07285197617676
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22767,88,1.32 [0.97-1.80],0.07285197617676
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16499,85,1.34 [0.98-1.84],0.0709087207173017
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Cardiomyopathy,20406,31,1.21 [0.66-2.21],0.5367853257926777
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Conduction disorders,20438,63,0.73 [0.40-1.35],0.3148878901891015
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14086,83,0.91 [0.58-1.43],0.6823146100676325
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,14238,235,0.99 [0.76-1.29],0.9634112346120882
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other arrhythmias,20418,43,0.93 [0.50-1.75],0.827706013393188
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,20422,47,0.62 [0.29-1.33],0.2190512830848688
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22751,82,0.98 [0.62-1.52],0.9123772011402096
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22786,109,0.90 [0.60-1.35],0.6026474768753465
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22821,82,0.95 [0.60-1.48],0.80788701514911
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22880,70,0.94 [0.57-1.53],0.7904675107387467
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22586,58,0.96 [0.57-1.62],0.8682908584015483
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22623,95,1.55 [1.22-1.98],0.0004278456242115
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22072,110,1.08 [0.77-1.52],0.6532644101693702
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22049,87,0.95 [0.61-1.46],0.8001452020151125
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23251,86,0.92 [0.59-1.43],0.7167292144226519
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Varicose veins,22488,526,0.93 [0.78-1.12],0.4557203719720681
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypotension,22506,71,1.13 [0.75-1.70],0.5512257926594586
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,19071,1799,1.04 [0.95-1.14],0.3869027573113324
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23251,114,1.46 [1.15-1.85],0.0016452653849413
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22082,173,1.31 [1.05-1.65],0.0177370830980103
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22065,156,1.21 [0.93-1.57],0.1569084185958641
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22664,202,1.20 [0.96-1.51],0.1164409955631138
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22659,197,1.23 [0.98-1.54],0.0754067577935418
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22784,481,0.88 [0.72-1.07],0.1886313403072609
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Chronic sinusitis,22406,103,0.91 [0.61-1.37],0.6541804485739408
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Nasal polyp,22373,70,0.92 [0.57-1.51],0.7553578199288647
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22606,303,0.86 [0.67-1.10],0.224250571431756
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Deviated nasal septum,22422,119,0.96 [0.68-1.38],0.8430064657596695
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11274,55,0.86 [0.48-1.56],0.6238769058624114
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,20898,987,1.00 [0.88-1.13],0.9965785590508855
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Early onset COPD,22554,134,1.08 [0.79-1.47],0.6482555653862143
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22571,151,1.10 [0.82-1.47],0.5229760754495881
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",22571,151,1.10 [0.82-1.47],0.5229760754495881
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",21665,847,0.93 [0.81-1.07],0.3266662896770451
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Asthma,17421,847,0.93 [0.80-1.07],0.3179502843006411
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",17265,847,0.93 [0.80-1.07],0.3087047562985375
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",17409,835,0.94 [0.81-1.08],0.3798700274113298
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23164,76,1.50 [1.13-2.00],0.0056987862828117
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Interstitial lung disease,21878,58,1.67 [1.26-2.23],0.0004029355252193
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",23226,58,1.66 [1.25-2.22],0.0004679314897627
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21871,51,1.52 [1.07-2.15],0.0190252915705921
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pleural effusion,21885,70,1.19 [0.80-1.76],0.3931673224746953
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other diseases of pleura,21978,163,1.23 [0.97-1.58],0.0937389095337753
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,22452,78,1.23 [0.86-1.75],0.2604838398852359
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16251,5092,1.05 [0.99-1.12],0.1257495014636182
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22945,397,0.84 [0.67-1.05],0.121974406934885
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23400,88,0.84 [0.54-1.33],0.4606481451014246
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Impacted teeth,23405,80,0.85 [0.53-1.36],0.4928076768468618
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Dental caries,22639,91,1.08 [0.73-1.58],0.7045400820180515
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22647,99,0.86 [0.56-1.32],0.479262735218061
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23391,96,0.81 [0.52-1.26],0.350608039934427
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22642,94,0.62 [0.36-1.07],0.0836883898686079
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22392,61,0.64 [0.33-1.25],0.1911798003107869
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23318,39,0.37 [0.14-0.97],0.0428376304055721
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,17727,185,0.79 [0.55-1.11],0.1750700413447197
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",19509,1967,1.08 [0.99-1.18],0.0725227944977833
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oesophagitis,17789,247,1.09 [0.87-1.38],0.4538856355778946
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18174,632,1.14 [0.98-1.31],0.0818799305849168
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,17606,64,1.40 [1.00-1.97],0.0518717429220585
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17660,118,1.37 [1.05-1.79],0.0220953907702012
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17574,32,0.31 [0.10-0.94],0.038249249580408
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastric ulcer,17664,122,0.84 [0.55-1.26],0.3910905832014494
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Duodenal ulcer,17605,63,0.82 [0.46-1.47],0.5056499082587114
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23361,49,0.85 [0.45-1.59],0.6110242048743405
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Chronic gastritis,17652,110,0.92 [0.61-1.38],0.6795657095631076
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18264,722,1.04 [0.90-1.20],0.6079874623787178
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of appendix,23299,130,0.96 [0.68-1.35],0.8126635079694415
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Functional dyspepsia,18039,497,0.99 [0.82-1.18],0.8932933513963847
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,17685,143,1.21 [0.92-1.60],0.1790198975505542
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23323,124,1.00 [0.71-1.40],0.9856190044561424
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute appendicitis,23276,107,1.00 [0.70-1.44],0.9829379735674352
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Hernia,20991,1025,1.22 [1.10-1.37],0.0002918560808782
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Inguinal hernia,20024,58,0.93 [0.54-1.62],0.8004891358668031
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Umbilical hernia,20030,64,1.29 [0.85-1.93],0.2279825609265908
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ventral hernia,20052,86,1.28 [0.91-1.80],0.1567572193233468
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20788,822,1.22 [1.08-1.38],0.0017753085277831
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22517,774,1.05 [0.92-1.21],0.4373007031710327
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of intestines,18594,1851,1.04 [0.95-1.14],0.382920135389877
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23159,54,0.77 [0.41-1.44],0.4192392265998037
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23388,78,1.00 [0.65-1.53],0.9988673484070768
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Crohn disease,21821,78,1.00 [0.66-1.54],0.9821722815559778
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21800,57,1.13 [0.73-1.76],0.580281487391748
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23320,112,1.04 [0.73-1.47],0.8402331407733251
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ulcerative colitis,21855,112,1.04 [0.73-1.47],0.8254776642262144
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21841,98,1.08 [0.76-1.55],0.6714459804290827
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22401,658,1.07 [0.93-1.24],0.3565730734741068
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22391,648,1.08 [0.94-1.25],0.2780479364234516
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,16829,86,1.23 [0.89-1.72],0.2115300369377748
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Intestinal stricture,23033,86,1.24 [0.89-1.74],0.2030195477053511
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16797,54,1.36 [0.94-1.96],0.0976146550181467
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,17311,568,1.00 [0.85-1.19],0.9754402031735
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16944,201,1.13 [0.89-1.43],0.3197250761547663
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,17069,326,1.09 [0.90-1.33],0.3681133434586663
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Constipation,22004,291,1.10 [0.89-1.35],0.3895239257921951
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23007,107,0.69 [0.43-1.11],0.1259084314592609
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16853,110,1.01 [0.71-1.44],0.94470158538662
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16781,38,0.87 [0.44-1.74],0.697528628233181
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17500,757,0.98 [0.85-1.13],0.7961328022003952
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of intestine,16943,200,0.84 [0.61-1.15],0.2799507429148574
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,22994,94,0.66 [0.39-1.10],0.1113236658016878
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of liver,22769,85,1.32 [0.96-1.80],0.0845483301560927
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of liver,22729,45,1.67 [1.22-2.29],0.0013497219520821
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22096,734,0.98 [0.84-1.13],0.7666489351191978
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Cholelithiasis,21973,611,0.97 [0.83-1.14],0.7331605308542983
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Cholecystitis,21474,112,0.59 [0.36-0.97],0.0393128569164285
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21417,55,1.33 [0.91-1.93],0.1404104965044821
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute pancreatitis,21412,50,1.24 [0.80-1.93],0.3396953981459533
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),23301,50,1.25 [0.80-1.95],0.3190118292512391
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22270,254,1.25 [1.03-1.52],0.0220168648386022
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22103,87,1.65 [1.32-2.08],1.58987782837043e-05
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Coeliac disease,22091,75,1.66 [1.30-2.12],5.7006613036855406e-05
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22049,33,1.13 [0.63-2.02],0.6736661139460001
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22155,139,0.93 [0.66-1.32],0.6768912647120782
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,GI-bleeding,22147,131,0.95 [0.67-1.35],0.7708742030826807
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,20756,1379,1.01 [0.91-1.12],0.8757285374111399
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23040,100,0.92 [0.61-1.40],0.7050724014110605
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23054,389,0.98 [0.80-1.19],0.8226125070038796
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22106,587,1.06 [0.91-1.24],0.4564672386624044
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22730,278,1.02 [0.81-1.29],0.8615237469394312
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22516,64,0.95 [0.57-1.57],0.8404870959691133
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22629,177,1.03 [0.77-1.37],0.8673239933551219
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23180,77,0.72 [0.41-1.26],0.2490426222009012
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23158,55,0.90 [0.51-1.59],0.7266356465811546
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23145,42,1.07 [0.61-1.86],0.8137209898772166
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23217,50,0.85 [0.46-1.58],0.6097138442406204
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23214,47,0.84 [0.44-1.60],0.6031071759545208
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22715,50,0.72 [0.36-1.44],0.3505977419031231
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22969,304,1.02 [0.82-1.27],0.8435754578316079
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21603,84,0.95 [0.61-1.47],0.8083198798254236
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21648,129,1.02 [0.73-1.43],0.886988673748049
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21613,94,1.00 [0.68-1.49],0.9844657308561688
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21736,217,0.89 [0.66-1.19],0.4264833278668296
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21715,196,0.88 [0.65-1.20],0.4088720562661426
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,16511,3754,0.99 [0.92-1.07],0.8485338233146251
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,17990,2155,1.00 [0.92-1.10],0.9283585972015672
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21036,1134,0.89 [0.79-1.02],0.0843140905144017
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16026,191,1.18 [0.93-1.50],0.1616169090505834
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16278,443,1.01 [0.84-1.22],0.8882476855372388
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",22954,183,1.23 [0.98-1.55],0.073881434856204
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,22968,168,1.25 [0.98-1.58],0.0668816746446703
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,16872,1037,1.03 [0.91-1.17],0.6383733976117231
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",19168,1037,1.04 [0.92-1.18],0.5468458852647345
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,15846,11,1.27 [0.49-3.29],0.6203988162242773
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23277,11,1.30 [0.50-3.38],0.5966016729392096
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,16061,226,0.76 [0.55-1.04],0.08896823126025
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,15910,75,1.21 [0.83-1.76],0.3300099052331278
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,16101,266,1.20 [0.98-1.47],0.0764226727699855
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23259,138,1.23 [0.93-1.61],0.1404136704654691
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,16236,401,0.90 [0.72-1.12],0.3489725039238253
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,16237,402,0.92 [0.74-1.14],0.4318827213337119
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,17036,1201,0.93 [0.83-1.06],0.2726993777599404
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),15934,99,0.92 [0.61-1.40],0.7083528706154323
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16190,355,1.06 [0.87-1.29],0.5845620408064873
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,15903,68,1.16 [0.77-1.75],0.4790027982014965
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),15923,88,1.19 [0.84-1.69],0.325379656703933
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16148,313,1.02 [0.82-1.27],0.860382301835598
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16101,266,1.08 [0.87-1.35],0.4773150137462665
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17428,253,0.92 [0.71-1.20],0.5420503491023767
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22717,207,1.37 [1.12-1.66],0.0019215298404828
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22592,82,1.41 [1.05-1.90],0.0235726033655185
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20068,73,0.69 [0.38-1.23],0.2101565964806225
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,20265,270,0.89 [0.68-1.15],0.375816161452652
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,20877,882,0.96 [0.84-1.10],0.5962776029940042
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20182,187,0.87 [0.63-1.19],0.3819354640536706
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20064,69,0.91 [0.54-1.51],0.7074676602898278
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",20699,704,1.01 [0.87-1.17],0.883533103874345
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20037,42,0.81 [0.41-1.62],0.5569893878885761
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20203,208,1.03 [0.79-1.33],0.8480855009066856
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20084,89,1.05 [0.71-1.54],0.8047389135353132
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20069,74,0.74 [0.42-1.29],0.285448161288706
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20124,129,1.01 [0.72-1.42],0.9421728874007926
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20063,68,1.46 [1.07-1.99],0.0181636650910215
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20304,309,0.93 [0.73-1.17],0.537889150230024
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20232,330,0.74 [0.57-0.97],0.0265471195105467
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19963,61,0.86 [0.50-1.50],0.6065498955166333
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19995,93,0.91 [0.59-1.41],0.6742897357353883
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20023,121,0.68 [0.43-1.07],0.0914755503991525
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19939,37,1.05 [0.58-1.90],0.8705553120466287
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19948,46,0.99 [0.56-1.75],0.9695029160639398
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19937,35,1.23 [0.73-2.07],0.4394989262757595
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20133,231,1.08 [0.85-1.36],0.549951034280828
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19953,51,1.27 [0.83-1.94],0.2620015919380318
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19958,56,0.99 [0.59-1.68],0.97512164383987
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20015,113,0.78 [0.51-1.21],0.2712536673892872
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19973,71,0.81 [0.47-1.37],0.4264801227608239
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20368,466,0.91 [0.75-1.10],0.3182021370054798
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20067,165,0.83 [0.59-1.17],0.2987740028557664
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20158,256,0.98 [0.76-1.25],0.8510934691270009
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,21119,208,1.11 [0.87-1.42],0.4012398889849382
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,21317,406,1.08 [0.90-1.29],0.416246042999608
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20944,33,0.75 [0.33-1.70],0.490212462158574
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20960,49,1.20 [0.76-1.90],0.4334367913551188
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21001,90,1.24 [0.90-1.72],0.183156495628859
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,19227,5256,1.01 [0.95-1.08],0.6915194366686557
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,21459,149,0.99 [0.71-1.36],0.9278184677551004
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21345,35,0.53 [0.21-1.34],0.180074719157434
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21626,25,1.34 [0.74-2.44],0.3348646813581099
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21630,29,1.24 [0.67-2.27],0.4920111921672065
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21631,30,1.50 [0.95-2.36],0.0801610023921968
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23228,104,1.34 [1.02-1.76],0.0371174593483156
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23142,50,0.67 [0.33-1.38],0.2779965697215357
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23202,78,1.40 [1.03-1.88],0.029883495855363
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23155,31,1.72 [1.20-2.47],0.003167940193926
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,21577,1076,1.03 [0.91-1.16],0.6410527787329448
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Cystitis,20607,106,0.91 [0.61-1.36],0.6437405038671351
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20574,73,0.94 [0.58-1.50],0.7849398606253359
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20641,140,1.36 [1.07-1.72],0.0111748835876449
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20580,79,1.18 [0.81-1.70],0.3862125487306502
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21353,852,1.00 [0.87-1.14],0.9511061274473108
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23177,417,1.00 [0.83-1.20],0.9749875671958728
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,22888,128,0.91 [0.63-1.31],0.6068980984968337
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,22902,142,1.17 [0.89-1.54],0.2704384033169504
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,22864,104,0.82 [0.53-1.27],0.3713552538270257
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23118,479,1.04 [0.88-1.23],0.6206660003289759
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,22754,115,1.14 [0.83-1.55],0.4218224783211046
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,22853,214,1.13 [0.90-1.42],0.2943067112097566
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,21385,3943,1.00 [0.93-1.07],0.9529391732490564
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Endometriosis,17743,301,0.94 [0.75-1.18],0.5877839179112365
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,17527,85,0.82 [0.52-1.31],0.4105960692372705
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17578,136,0.94 [0.67-1.32],0.7178226128074197
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18127,685,1.12 [0.98-1.28],0.1013059874943568
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17785,343,0.93 [0.75-1.16],0.5313246063206887
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18259,817,0.99 [0.86-1.13],0.854796726011031
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17714,272,1.05 [0.84-1.30],0.6925033708658863
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17820,378,1.02 [0.84-1.24],0.8446430809116139
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,17527,85,0.74 [0.45-1.22],0.2371897891963981
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,17606,164,1.11 [0.85-1.44],0.4402845958537094
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",23403,228,1.20 [0.97-1.48],0.0948349327328532
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,23412,216,1.19 [0.96-1.48],0.1084414948698134
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,23432,117,1.31 [1.01-1.70],0.0421954729641129
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",23424,129,1.30 [1.01-1.67],0.0384133327126414
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17567,125,1.21 [0.91-1.60],0.1918282753293616
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17545,103,0.90 [0.59-1.35],0.6045711659080817
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17563,121,0.82 [0.54-1.22],0.3262889487932248
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Irregular menses,23345,396,1.02 [0.85-1.23],0.8172728054091853
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18597,1155,1.03 [0.92-1.15],0.6258720017906969
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Menorrhagia,18197,755,1.01 [0.88-1.15],0.9385249419341098
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",23421,172,1.02 [0.77-1.35],0.880561128125581
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17838,396,0.99 [0.82-1.20],0.9090573079797216
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17710,268,1.06 [0.86-1.31],0.5698883985348336
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18223,781,1.02 [0.88-1.17],0.8333969083825421
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Female infertility,17529,87,0.79 [0.49-1.26],0.3224725870999481
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",17522,80,0.83 [0.52-1.33],0.4390929821071172
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,23429,723,0.93 [0.79-1.08],0.3335643507784767
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,23435,988,0.85 [0.74-0.99],0.0317957476316758
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,23430,384,0.89 [0.72-1.10],0.2967377568046401
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,23155,109,0.79 [0.51-1.21],0.273151166335132
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,23202,156,0.74 [0.51-1.07],0.1089903477478918
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,23180,134,1.20 [0.92-1.57],0.1815348984644421
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",23445,140,0.98 [0.71-1.34],0.8805680791849739
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,23447,139,0.97 [0.70-1.33],0.830826054583045
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,23444,355,0.84 [0.66-1.05],0.1314498029455337
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,23193,104,0.85 [0.57-1.28],0.4459596518416188
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,23289,200,0.70 [0.50-0.99],0.0446439520322046
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,22829,123,1.25 [0.95-1.64],0.1105623781292347
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,22874,168,1.19 [0.94-1.52],0.1556732748471849
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,22908,202,0.91 [0.68-1.20],0.4962894310209049
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,22831,125,0.69 [0.45-1.06],0.0919146811013173
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,22821,115,0.84 [0.57-1.25],0.3901272871158104
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,22825,119,0.70 [0.46-1.08],0.1110123745685216
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,22638,191,0.81 [0.59-1.12],0.2098744486887918
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],22809,362,0.86 [0.69-1.08],0.1966604006632802
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,22997,550,0.84 [0.69-1.01],0.0670529813439583
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",23449,143,0.83 [0.58-1.19],0.3116167140914457
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,22248,110,0.76 [0.49-1.17],0.2130138322021142
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",22528,81,1.02 [0.69-1.52],0.9112318462639032
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,23455,277,0.96 [0.76-1.21],0.7027189851675711
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,23393,215,0.81 [0.60-1.09],0.1732213244648218
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",23444,208,0.83 [0.61-1.12],0.2159943937694735
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",23434,198,0.76 [0.55-1.06],0.1015963834461388
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23197,42,0.94 [0.49-1.77],0.8359686383796188
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Falls/tendency to fall,21008,534,0.94 [0.79-1.12],0.5087437156148713
